Literature DB >> 29657083

The course of awake breathing disturbances across the lifespan in Rett syndrome.

Daniel C Tarquinio1, Wei Hou2, Jeffrey L Neul3, Gamze Kilic Berkmen4, Jana Drummond4, Elizabeth Aronoff4, Jennifer Harris5, Jane B Lane6, Walter E Kaufmann7, Kathleen J Motil8, Daniel G Glaze8, Steven A Skinner7, Alan K Percy6.   

Abstract

Rett syndrome (RTT), an X-linked dominant neurodevelopmental disorder caused by mutations in MECP2, is associated with a peculiar breathing disturbance exclusively during wakefulness that is distressing, and can even prompt emergency resuscitation. Through the RTT Natural History Study, we characterized cross sectional and longitudinal characteristics of awake breathing abnormalities in RTT and identified associated clinical features. Participants were recruited from 2006 to 2015, and cumulative lifetime prevalence of breathing dysfunction was determined using the Kaplan-Meier estimator. Risk factors were assessed using logistic regression. Of 1205 participants, 1185 had sufficient data for analysis, including 922 females with classic RTT, 778 of whom were followed longitudinally for up to 9.0 years, for a total of 3944 person-years. Participants with classic or atypical severe RTT were more likely to have breathing dysfunction (nearly 100% over the lifespan) compared to those with atypical mild RTT (60-70%). Remission was common, lasting 1 year on average, with 15% ending the study in terminal remission. Factors associated with higher odds of severe breathing dysfunction included poor gross and fine motor function, frequency of stereotypical hand movements, seizure frequency, prolonged corrected QT interval on EKG, and two quality of life metrics: caregiver concern about physical health and contracting illness. Factors associated with lower prevalence of severe breathing dysfunction included higher body mass index and head circumference Z-scores, advanced age, and severe scoliosis or contractures. Awake breathing dysfunction is common in RTT, more so than seizures, and is associated with function, quality of life and risk for cardiac dysrhythmia.
Copyright © 2018 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dysautonomia; MECP2; Natural History Study; Periodic breathing; Rett syndrome

Mesh:

Year:  2018        PMID: 29657083      PMCID: PMC6026556          DOI: 10.1016/j.braindev.2018.03.010

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  60 in total

1.  The Changing Face of Survival in Rett Syndrome and MECP2-Related Disorders.

Authors:  Daniel C Tarquinio; Wei Hou; Jeffrey L Neul; Walter E Kaufmann; Daniel G Glaze; Kathleen J Motil; Steven A Skinner; Hye-Seung Lee; Alan K Percy
Journal:  Pediatr Neurol       Date:  2015-06-26       Impact factor: 3.372

2.  Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome.

Authors:  Debra E Weese-Mayer; Steven P Lieske; Christina M Boothby; Anna S Kenny; Heather L Bennett; Jean M Silvestri; Jan-Marino Ramirez
Journal:  Pediatr Res       Date:  2006-08-28       Impact factor: 3.756

3.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.

Authors:  J Guy; B Hendrich; M Holmes; J E Martin; A Bird
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

4.  Rett syndrome--an early catecholamine and indolamine deficient disorder?

Authors:  Y Nomura; M Segawa; M Higurashi
Journal:  Brain Dev       Date:  1985       Impact factor: 1.961

5.  Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil.

Authors:  Claudio De Felice; Cinzia Signorini; Thierry Durand; Lucia Ciccoli; Silvia Leoncini; Maurizio D'Esposito; Stefania Filosa; Camille Oger; Alexandre Guy; Valérie Bultel-Poncé; Jean-Marie Galano; Alessandra Pecorelli; Laura De Felice; Giuseppe Valacchi; Joussef Hayek
Journal:  Genes Nutr       Date:  2012-03-08       Impact factor: 5.523

Review 6.  Mental retardation, "coarse" face, and hyperbreathing: confirmation of the Pitt-Hopkins syndrome.

Authors:  I D Van Balkom; S Quartel; R C Hennekam
Journal:  Am J Med Genet       Date:  1998-01-23

7.  Management of a severe forceful breather with Rett syndrome using carbogen.

Authors:  Eric E J Smeets; Peter O O Julu; Dick van Waardenburg; Ingegerd Witt Engerström; Stig Hansen; Flora Apartopoulos; Leopold M G Curfs; Connie T R M Schrander-Stumpel
Journal:  Brain Dev       Date:  2006-06-09       Impact factor: 1.961

Review 8.  Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth.

Authors:  David M Katz; Mathias Dutschmann; Jan-Marino Ramirez; Gérard Hilaire
Journal:  Respir Physiol Neurobiol       Date:  2009-04-24       Impact factor: 1.931

9.  Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with Rett syndrome.

Authors:  Kathleen J Motil; Erwin Caeg; Judy O Barrish; Suzanne Geerts; Jane B Lane; Alan K Percy; Fran Annese; Lauren McNair; Steven A Skinner; Hye-Seung Lee; Jeffrey L Neul; Daniel G Glaze
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-09       Impact factor: 2.839

10.  Rett's syndrome: characterization of respiratory patterns and sleep.

Authors:  D G Glaze; J D Frost; H Y Zoghbi; A K Percy
Journal:  Ann Neurol       Date:  1987-04       Impact factor: 10.422

View more
  17 in total

1.  Autonomic dysfunction and sudden death in patients with Rett syndrome: a systematic review

Authors:  Jatinder Singh; Evamaria Lanzarini; Paramala Santosh
Journal:  J Psychiatry Neurosci       Date:  2020-05-01       Impact factor: 6.186

2.  The Pathophysiology of Rett Syndrome With a Focus on Breathing Dysfunctions.

Authors:  Jan-Marino Ramirez; Marlusa Karlen-Amarante; Jia-Der Ju Wang; Nicholas E Bush; Michael S Carroll; Debra E Weese-Mayer; Alyssa Huff
Journal:  Physiology (Bethesda)       Date:  2020-11-01

3.  Consensus guidelines on managing Rett syndrome across the lifespan.

Authors:  Cary Fu; Dallas Armstrong; Eric Marsh; David Lieberman; Kathleen Motil; Rochelle Witt; Shannon Standridge; Paige Nues; Jane Lane; Tristen Dinkel; Monica Coenraads; Jana von Hehn; Mary Jones; Katie Hale; Bernhard Suter; Daniel Glaze; Jeffrey Neul; Alan Percy; Timothy Benke
Journal:  BMJ Paediatr Open       Date:  2020-09-13

4.  Pharmacological read-through of R294X Mecp2 in a novel mouse model of Rett syndrome.

Authors:  Jonathan K Merritt; Bridget E Collins; Kirsty R Erickson; Hongwei Dong; Jeffrey L Neul
Journal:  Hum Mol Genet       Date:  2020-08-29       Impact factor: 6.150

5.  Biliary Tract Disease in Girls and Young Women With Rett Syndrome.

Authors:  Kathleen J Motil; Jane B Lane; Judy O Barrish; Fran Annese; Suzanne Geerts; Lauren McNair; Steven A Skinner; Jeffrey L Neul; Daniel G Glaze; Alan K Percy
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-06       Impact factor: 2.839

6.  Safety and efficacy of genetic MECP2 supplementation in the R294X mouse model of Rett syndrome.

Authors:  Bridget E Collins; Jonathan K Merritt; Kirsty R Erickson; Jeffrey L Neul
Journal:  Genes Brain Behav       Date:  2021-05-19       Impact factor: 3.449

Review 7.  Rett syndrome: think outside the (skull) box.

Authors:  Emilie Borloz; Laurent Villard; Jean-Christophe Roux
Journal:  Fac Rev       Date:  2021-06-29

8.  Potent hERG channel inhibition by sarizotan, an investigative treatment for Rett Syndrome.

Authors:  Hongwei Cheng; Chunyun Du; Yihong Zhang; Andrew F James; Christopher E Dempsey; Ana P Abdala; Jules C Hancox
Journal:  J Mol Cell Cardiol       Date:  2019-07-27       Impact factor: 5.000

9.  Dental procedure under opioid-free balanced anaesthesia in a child with Rett syndrome who convulsed on every attempt to feed: Case report.

Authors:  Vrushali Ponde; Ankit Desai; Karthic Ekambaram; Selabh Thakur
Journal:  Indian J Anaesth       Date:  2020-03-28

10.  Detection of neurophysiological features in female R255X MeCP2 mutation mice.

Authors:  Hong-Wei Dong; Kirsty Erickson; Jessica R Lee; Jonathan Merritt; Cary Fu; Jeffrey L Neul
Journal:  Neurobiol Dis       Date:  2020-09-12       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.